EGFR and non-small cell lung carcinoma: PMS2 is related to DNA mismatch repair and might accelerate tumorigenesis [26], and MET copy number gains are associated with EGFR tyrosine kinase inhibitors (TKIs) resistance in NSCLC with BMs [27].